Privately held Seamless Therapeutics announced a global research and licensing agreement worth up to $1.12B with Eli Lilly to develop gene-editing treatments for hearing loss.

#LLYStock #EliLilly#GeneEditing #SeamlessTherapeutics #Biotech

Nvidia is expanding into life sciences through major partnerships and platform upgrades linking digital AI with physical laboratory work

#NVDA #LLY #TMO #Nvidia #EliLilly #ThermoFisher #NVDAStock #NvidiaNews #LLYStock #EliLillyNews #TMOStock #ThermoFisherNews #BioNeMo
$NVDA $LLY $TMO